Published in Biomed Res Int on February 28, 2013
Intracellular signal modulation by nanomaterials. Adv Exp Med Biol (2014) 0.78
HTCC-modified nanoclay for tissue engineering applications: a synergistic cell growth and antibacterial efficiency. Biomed Res Int (2013) 0.78
Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater (2009) 11.95
RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol (1996) 9.77
Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm (2008) 7.67
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci (1999) 3.93
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta (2001) 3.25
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med (2005) 3.19
Signaling through focal adhesion kinase. Bioessays (1997) 2.77
Cell adhesion: old and new questions. Trends Cell Biol (1999) 2.44
Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J (2007) 2.38
Fibronectin adsorption on hydrophilic and hydrophobic surfaces detected by antibody binding and analyzed during cell adhesion in serum-containing medium. J Biol Chem (1982) 2.12
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Interaction of nanoparticles with cells. Biomacromolecules (2009) 1.73
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev (2001) 1.63
The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol Appl Pharmacol (2008) 1.50
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology (2009) 1.43
Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor. J Pharmacol Exp Ther (1997) 1.37
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Negative regulation of FAK signaling by SOCS proteins. EMBO J (2003) 1.26
A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J Cell Sci (1989) 1.15
Nanoparticles: molecular targets and cell signalling. Arch Toxicol (2010) 1.09
Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: need for multiparametric evaluation due to adsorption artifacts. Inhal Toxicol (2009) 1.06
Disturbed mitotic progression and genome segregation are involved in cell transformation mediated by nano-TiO2 long-term exposure. Toxicol Appl Pharmacol (2009) 1.05
Magnetic micro- and nanoparticle mediated activation of mechanosensitive ion channels. Med Eng Phys (2005) 1.04
Plasmin cleavage of vitronectin. Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1. FEBS Lett (1991) 1.03
Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. FEBS Lett (1996) 0.99
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir (2012) 0.99
A tiny touch: activation of cell signaling pathways with magnetic nanoparticles. Endocrinology (2009) 0.93
Transferrin coated nanoparticles: study of the bionano interface in human plasma. PLoS One (2012) 0.86
Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J Control Release (2005) 0.84
A new biocompatible nanoparticle delivery system for the release of fibrinolytic drugs. Int J Pharm (2008) 0.84
Development and evaluation of cyclodextrin complexed hydroxyapatite nanoparticles for preferential albumin adsorption. Colloids Surf B Biointerfaces (2011) 0.81
Mediation of the migration of endothelial cells and fibroblasts on polyurethane nanocomposites by the activation of integrin-focal adhesion kinase signaling. J Biomed Mater Res A (2011) 0.80
The leukocyte beta 1 integrins. Curr Opin Hematol (1995) 0.80
Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells. J Cell Physiol (2003) 0.79
Nanoparticle systems for the targeted release of active principles of proteic nature. J Mater Sci Mater Med (2003) 0.77
Adhesion and proliferation of fibroblasts on RF plasma-deposited nanostructured fluorocarbon coatings: evidence of FAK activation. J Cell Physiol (2006) 0.77
The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol (1988) 6.27
Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) (1996) 4.52
Recent techniques for tracing pathways in the central nervous system of developing and adult mammals. Brain Res Bull (2000) 1.82
Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med (2001) 1.75
Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA (1990) 1.66
Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase'. FEBS Lett (1995) 1.57
Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes (2000) 1.54
The structure of syringomycins A1, E and G. FEBS Lett (1989) 1.53
Cloning and sequencing of the gene coding for aspartate aminotransferase from the thermoacidophilic archaebacterium Sulfolobus solfataricus. Eur J Biochem (1989) 1.52
GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest (2004) 1.49
Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia. Diabetologia (2005) 1.46
[Diabetic microangiopathy. Role of capillaroscopy]. Presse Med (1989) 1.41
Purification and general properties of aspartate aminotransferase of ox heart. Biochem J (1966) 1.28
Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem Biophys Res Commun (1997) 1.27
The ilvIH operon of Escherichia coli K-12. Identification of the gene products and recognition of the translational start by polypeptide microsequencing. Biochim Biophys Acta (1985) 1.25
Topology of the calmodulin-melittin complex. J Mol Biol (1998) 1.22
Characterization of aromatic aminotransferases from the hyperthermophilic archaeon Thermococcus litoralis. Eur J Biochem (1994) 1.22
Oncology: a forgotten territory in Africa. Ann Oncol (2007) 1.22
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. Clin Chim Acta (2006) 1.18
Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur J Biochem (1991) 1.18
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes (2000) 1.17
Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: the case of Minibody. Protein Sci (1996) 1.11
KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis (2013) 1.10
An extremely thermostable aromatic aminotransferase from the hyperthermophilic archaeon Pyrococcus furiosus. Biochim Biophys Acta (1995) 1.09
Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study. Diabetologia (2008) 1.07
A novel replication element from an Antarctic plasmid as a tool for the expression of proteins at low temperature. Extremophiles (2001) 1.07
Syringopeptins, new phytotoxic lipodepsipeptides of Pseudomonas syringae pv. syringae. FEBS Lett (1991) 1.06
Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med (2004) 1.06
Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels. The TULIP study. Diabetes Obes Metab (2008) 1.04
Long-term outcome of patients who require renal replacement therapy after cardiac surgery. Eur J Anaesthesiol (2006) 1.04
Effects of fibronectin and laminin on structural, mechanical and transport properties of 3D collageneous network. J Mater Sci Mater Med (2007) 1.02
Anemia and diabetes. Am J Nephrol (2004) 1.02
Genetics and clinicopathological findings in thyroid carcinomas associated with familial adenomatous polyposis. Am J Pathol (1999) 1.01
Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab (2000) 1.00
Penile fracture: an unusual presentation with lacerations of bilateral corpora cavernosa and partial disruption of the urethra. Urology (1994) 1.00
Incidence and characteristics of lower limb amputations in people with diabetes. Diabet Med (2009) 0.99
Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif (2011) 0.98
Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl (2001) 0.98
Amino acid sequence and disulphide-bridge pattern of three gamma-thionins from Sorghum bicolor. Eur J Biochem (1995) 0.98
[Purification of aspartate aminotransferase from the bovine heart]. Boll Soc Ital Biol Sper (1965) 0.98
Surface topology of Minibody by selective chemical modifications and mass spectrometry. Protein Sci (1997) 0.98
Purification, characterization, and functional role of a novel extracellular protease from Pleurotus ostreatus. Appl Environ Microbiol (2001) 0.96
Aspartate aminotransferase from the Antarctic bacterium Pseudoalteromonas haloplanktis TAC 125. Cloning, expression, properties, and molecular modelling. Eur J Biochem (2000) 0.96
Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. Minerva Anestesiol (2010) 0.96
Carnitine: an osmolyte that plays a metabolic role. J Cell Biochem (2000) 0.96
Acute renal failure after isolated CABG surgery: six years of experience. Minerva Anestesiol (2007) 0.95
Xylanase from the psychrophilic yeast Cryptococcus adeliae. Extremophiles (2000) 0.95
Short- and long-term effects of a dietary yeast beta-glucan (Macrogard) and alginic acid (Ergosan) preparation on immune response in sea bass (Dicentrarchus labrax). Fish Shellfish Immunol (2005) 0.95
Management of French patients with type 2 diabetes mellitus in medical general practice: report of the Mediab observatory. Diabetes Metab (2004) 0.95
Fine needle aspiration biopsy diagnosis of giant-cell tumor of bone. An experience with nine cases. Acta Cytol (1991) 0.94
Post-translational modifications in aspartate aminotransferase from Sulfolobus solfataricus. Detection of N-epsilon-methyllysines by mass spectrometry. Eur J Biochem (1994) 0.94
Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor. J Mol Biol (2001) 0.94
Limited proteolysis as a probe of conformational changes in aspartate aminotransferase from Sulfolobus solfataricus. Eur J Biochem (1992) 0.94
[Aspartate aminotransferase from bovine brain. II. Properties]. Boll Soc Ital Biol Sper (1964) 0.94
Absorption of sugars and amino acids by the epidermis of Aphidius ervi larvae. J Insect Physiol (2003) 0.93
Ageing and oxidative stress: a role for dolichol in the antioxidant machinery of cell membranes? J Alzheimers Dis (2004) 0.93
The effects of iodoprophylaxis on thyroid size during pregnancy. Am J Obstet Gynecol (1991) 0.93
Investigation of interactions between poly-L-lysine-coated boron nitride nanotubes and C2C12 cells: up-take, cytocompatibility, and differentiation. Int J Nanomedicine (2010) 0.93
Can local muscles augment stability in the hip? A narrative literature review. J Musculoskelet Neuronal Interact (2013) 0.92
Neurobiology of pain. J Cell Physiol (2006) 0.92
Early intermediates in the PDI-assisted folding of ribonuclease A. Protein Sci (2000) 0.92
Tryptophan biosynthesis genes trpEGC in the thermoacidophilic archaebacterium Sulfolobus solfataricus. J Bacteriol (1993) 0.92
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. Curr Med Chem (2006) 0.92
Analysis of RNase A refolding intermediates by electrospray/mass spectrometry. FEBS Lett (1994) 0.91
Nutrient absorption by Aphidius ervi larvae. J Insect Physiol (2005) 0.91
Localization of stilbene synthase in Vitis vinifera L. during berry development. Protoplasma (2008) 0.91
The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab (2009) 0.91
Simultaneous cisplatin and 5-fluorouracil as second-line treatment of head and neck cancer. Cancer Treat Rep (1987) 0.90
[A case of chronic schistosomiasis four years after infestation]. Urologia (2011) 0.90
Glutathione-dependent pathways of refolding of RNase T1 by oxidation and disulfide isomerization: catalysis by protein disulfide isomerase. Biochemistry (1996) 0.90
Effect of glutaredoxin and protein disulfide isomerase on the glutathione-dependent folding of ribonuclease A. Biochemistry (1997) 0.90
Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol (2000) 0.90
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab (2004) 0.90
Unexpected similarity of intestinal sugar absorption by SGLT1 and apical GLUT2 in an insect (Aphidius ervi, Hymenoptera) and mammals. Am J Physiol Regul Integr Comp Physiol (2007) 0.89
Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diabetes Care (1997) 0.89
Contribution of individual disulfide bonds to the oxidative folding of ribonuclease A. Biochemistry (2000) 0.89
Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med (1992) 0.89
Indole-3-glycerol-phosphate synthase from Sulfolobus solfataricus as a model for studying thermostable TIM-barrel enzymes. Biochim Biophys Acta (1994) 0.89
Characterisation of S-nitrosohaemoglobin by mass spectrometry. FEBS Lett (1997) 0.88
Stability of a thermophilic TIM-barrel enzyme: indole-3-glycerol phosphate synthase from the thermophilic archaeon Sulfolobus solfataricus. Biochem J (1997) 0.88
Childhood hepatocellular tumors in FAP. Gastroenterology (1997) 0.88
Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France--2001). Diabetes Metab (2003) 0.88
Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diabetes Care (1996) 0.88
Mass spectrometric analysis of the HMGY protein from Lewis lung carcinoma. Identification of phosphorylation sites. J Biol Chem (1992) 0.88
Opioids switching with transdermal systems in chronic cancer pain. J Exp Clin Cancer Res (2009) 0.87
Beta-endorphin modification by transglutaminase in vitro: identification by FAB/MS of glutamine-11 and lysine-29 as acyl donor and acceptor sites. Biochem Biophys Res Commun (1988) 0.87
Effect of physical parameters on the main phase transition of supported lipid bilayers. Biophys J (2009) 0.87
COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature. Clin Nephrol (2005) 0.87
Evaluation of the DCA 2000 system for glycated haemoglobin measurement. Diabetes Metab (1998) 0.87
Preparation of stable dispersion of barium titanate nanoparticles: Potential applications in biomedicine. Colloids Surf B Biointerfaces (2009) 0.87
In vitro synthesis of precursor forms of pig heart aspartate aminotransferase isozymes. Biochem Biophys Res Commun (1982) 0.87
Peritoneal carcinomatosis from colorectal cancer: HIPEC? Surg Oncol (2007) 0.87
Laparoscopic robot-assisted right adrenalectomy and left ovariectomy (case reports). Chir Ital (2000) 0.86
Expression of Sulfolobus solfataricus trpE and trpG genes in E. coli. Biochem Biophys Res Commun (1997) 0.86
Noradrenergic vascular hyper-responsiveness in human hypertension is dependent on oxygen free radical impairment of nitric oxide activity. Circulation (2000) 0.86
Impression cytology with scanning electron microscopy: a new method in the study of conjunctival microvilli. Eye (Lond) (2007) 0.85
Biodegradable nanomats produced by electrospinning: expanding multifunctionality and potential for tissue engineering. J Nanosci Nanotechnol (2006) 0.85
Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects. J Clin Endocrinol Metab (1986) 0.85
Variable expressivity of the acheiropodia gene. Am J Med Genet (1983) 0.85
Thyroid carcinoma usually occurs in patients with familial adenomatous polyposis in the absence of biallelic inactivation of the adenomatous polyposis coli gene. J Clin Endocrinol Metab (2001) 0.85